Fig. 5From: Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetesUrinary exosome markers a Wilm’s tumor-1 (WT-1), b Nephrin and c Podocalyxin (PODXL) were identified by Western blot and followed by quantification. A trend in reduced mean band intensities for Urinary exosome markers are observed in Canagliflozin group from visit 1 to visit 3 as compared to placebo groupBack to article page